Clinical management of cardiovascular risks during treatment with psychotropic drugs.

@article{Glassman2002ClinicalMO,
  title={Clinical management of cardiovascular risks during treatment with psychotropic drugs.},
  author={Alexander H. Glassman},
  journal={The Journal of clinical psychiatry},
  year={2002},
  volume={63 Suppl 9},
  pages={12-7}
}
The treatment of schizophrenia--as well as dementia, psychotic depression, and bipolar disorder--was greatly improved by the development of new atypical antipsychotic drugs in the past decade. However, cardiovascular and metabolic risks that are associated with some of these agents have become worrisome to clinicians and researchers. In this article, I will… CONTINUE READING